Janowsky A - Search Results

1

Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.

Eshleman AJ, Nagarajan S, Wolfrum KM, Reed JF, Swanson TL, Nilsen A, Janowsky A. Eshleman AJ, et al. Among authors: janowsky a. Psychopharmacology (Berl). 2019 Mar;236(3):939-952. doi: 10.1007/s00213-018-5059-5. Epub 2018 Nov 5. Psychopharmacology (Berl). 2019. PMID: 30397775 Free PMC article.

2

Characterization of a recombinant human dopamine transporter in multiple cell lines.

Eshleman AJ, Neve RL, Janowsky A, Neve KA. Eshleman AJ, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 1995 Jul;274(1):276-83. J Pharmacol Exp Ther. 1995. PMID: 7616409

3

Release of dopamine via the human transporter.

Eshleman AJ, Henningsen RA, Neve KA, Janowsky A. Eshleman AJ, et al. Among authors: janowsky a. Mol Pharmacol. 1994 Feb;45(2):312-6. Mol Pharmacol. 1994. PMID: 7906856

4

Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters.

Eshleman AJ, Stewart E, Evenson AK, Mason JN, Blakely RD, Janowsky A, Neve KA. Eshleman AJ, et al. Among authors: janowsky a. J Neurochem. 1997 Oct;69(4):1459-66. doi: 10.1046/j.1471-4159.1997.69041459.x. J Neurochem. 1997. PMID: 9326274 Free article.

5

[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.

Johnson RA, Eshleman AJ, Meyers T, Neve KA, Janowsky A. Johnson RA, et al. Among authors: janowsky a. Synapse. 1998 Sep;30(1):97-106. doi: 10.1002/(SICI)1098-2396(199809)30:1<97::AID-SYN12>3.0.CO;2-M. Synapse. 1998. PMID: 9704886

6

Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.

Eshleman AJ, Carmolli M, Cumbay M, Martens CR, Neve KA, Janowsky A. Eshleman AJ, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 1999 May;289(2):877-85. J Pharmacol Exp Ther. 1999. PMID: 10215666

7

Glutamate uptake in mice bred for ethanol withdrawal severity.

Buckman JF, Meshul CK, Finn DA, Janowsky A. Buckman JF, et al. Among authors: janowsky a. Psychopharmacology (Berl). 1999 Apr;143(2):174-82. doi: 10.1007/s002130050933. Psychopharmacology (Berl). 1999. PMID: 10326780

8

Drug interactions with the dopamine transporter in cryopreserved human caudate.

Eshleman AJ, Wolfrum K, Mash DC, Christensen K, Janowsky A. Eshleman AJ, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 2001 Feb;296(2):442-9. J Pharmacol Exp Ther. 2001. PMID: 11160629

9

NMDA receptor subunit mRNA and protein expression in ethanol-withdrawal seizure-prone and -resistant mice.

Mason JN, Eshleman AJ, Belknap JK, Crabbe JC, Loftis JM, Macey TA, Janowsky A. Mason JN, et al. Among authors: janowsky a. Alcohol Clin Exp Res. 2001 May;25(5):651-60. Alcohol Clin Exp Res. 2001. PMID: 11371713

10

Mapping genes that regulate density of dopamine transporters and correlated behaviors in recombinant inbred mice.

Janowsky A, Mah C, Johnson RA, Cunningham CL, Phillips TJ, Crabbe JC, Eshleman AJ, Belknap JK. Janowsky A, et al. J Pharmacol Exp Ther. 2001 Aug;298(2):634-43. J Pharmacol Exp Ther. 2001. PMID: 11454925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page